5EE7
Crystal structure of the human glucagon receptor (GCGR) in complex with the antagonist MK-0893
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I04 |
Synchrotron site | Diamond |
Beamline | I04 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2014-11-21 |
Detector | DECTRIS PILATUS 6M |
Wavelength(s) | 0.97949 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 37.583, 71.476, 183.108 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 19.971 - 2.500 |
R-factor | 0.2275 |
Rwork | 0.226 |
R-free | 0.26250 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4l6r |
RMSD bond length | 0.004 |
RMSD bond angle | 0.796 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | PHENIX (1.9_1692) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 32.730 | 2.600 |
High resolution limit [Å] | 2.500 | 2.500 |
Rmerge | 0.157 | 0.768 |
Number of reflections | 16065 | |
<I/σ(I)> | 6 | 1.6 |
Completeness [%] | 91.1 | 90.2 |
Redundancy | 3.3 | 3.3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | LIPIDIC CUBIC PHASE | 6 | 293.15 | ADA BUFFER, SODIUM POTASSIUM TARTRATE, PEG 400 |